Cargando…
Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801140/ https://www.ncbi.nlm.nih.gov/pubmed/34870380 http://dx.doi.org/10.1002/mgg3.1813 |
| _version_ | 1784642389490532352 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8801140 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88011402022-02-04 Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548 Mol Genet Genomic Med Retraction John Wiley and Sons Inc. 2021-12-06 /pmc/articles/PMC8801140/ /pubmed/34870380 http://dx.doi.org/10.1002/mgg3.1813 Text en © 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548 |
| title | Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
|
| title_full | Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
|
| title_fullStr | Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
|
| title_full_unstemmed | Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
|
| title_short | Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
|
| title_sort | retracted: yu, l., li, h., liu, w., zhang, l., tian, q., li, h., & li, m. (2021). mir‐485‐3p serves as a biomarker and therapeutic target of alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting akt3. molecular genetics & genomic medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548 |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801140/ https://www.ncbi.nlm.nih.gov/pubmed/34870380 http://dx.doi.org/10.1002/mgg3.1813 |